TANDEM DIABETES CARE INC
TNDM · XNASCIK 1438133fmd_1225CH9HAB0KV3NBYENV8KEZ5SManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2012 to Sep 30, 2026, 56 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 84 | 108 | 184 | 362 | 499 | 703 | 801 | 748 | 940 | 1,015 |
| Cost of revenue | 61 | 64 | 94 | 168 | 238 | 327 | 388 | 380 | 451 | 469 |
| Gross profit | 24 | 44 | 90 | 194 | 261 | 376 | 413 | 368 | 490 | 546 |
| Research and development | 19 | 21 | 29 | 45 | 64 | 92 | 139 | 170 | 199 | 193 |
| Selling, general and administrative | 83 | 86 | 105 | 166 | 205 | 262 | 336 | 353 | 390 | 445 |
| Total operating expenses | 102 | 107 | 134 | 211 | 268 | 354 | 506 | 601 | 589 | 733 |
| Operating income | (78) | (63) | (45) | (17) | (8) | 23 | (93) | (233) | (99) | (187) |
| Interest expense | – | – | – | – | – | – | 6 | 10 | 7 | 8 |
| Interest and investment income | 0 | 0 | 1 | 3 | 2 | 1 | 6 | 23 | 18 | – |
| Other non-operating income (expense) | (5) | (10) | (78) | (8) | (28) | (7) | (0) | 13 | 7 | (13) |
| Income before taxes | (83) | (73) | (123) | (25) | (36) | 16 | (93) | (220) | (92) | (200) |
| Income tax expense | (0) | 0 | 0 | 0 | (2) | 0 | 2 | 2 | 4 | 4 |
| Net income from continuing operations | (83) | (73) | (123) | (25) | (34) | 16 | (95) | (223) | (96) | (205) |
| Net income | (83) | (73) | (123) | (25) | (34) | 16 | (95) | (223) | (96) | (205) |
| Net income to common shareholders | – | – | – | – | (34) | 16 | (95) | (223) | – | – |